|
|
|
|
| Bioprocess Online is excited to introduce Bio-Expo Live, a series of live virtual events designed to empower biopharma professionals with the chance to conveniently explore the newest equipment and offerings in Upstream Bioprocessing, Downstream Bioprocessing and Bioprocess Quality, Data, and Analytical Solutions. Registration is free, reserve your spot today! |
|
|
|
|
By BioPhorum | Regulatory authorities advocate using alternative adventitious agent tests, but adoption has been slow. Here’s how to validate an alternative mycoplasma detection assay. |
|
|
|
| Risk Control | Bulk Filling Application | Webinar | Cytiva | Learn about a bulk filling system that enables you to achieve risk control, accuracy, and superior product recovery in your fill and finish operations. |
|
|
|
|
|
|
|
|
| A ballooning clinical-stage ADC development community is putting stress on both manufacturing capacity and antibody engineering and conjugation talent. What does this burgeon mean for ADC manufacturing, process development, and, ultimately, clinical progress? Join Bioprocess Online Live on July 9th as we navigate the complexity of the ADC manufacturing environment. From linkers to payloads to conjugation, we’ll cover the lay of the land for developers. Registration is free thanks to the support of Cytiva. |
|
|
|
|
By Charlie Wakeham, WakeUp to Quality | Innovation and improvement are often used synonymously, but sometimes innovation hinders more than helps. Here’s a cold-eyed look at recent blockbuster tech advances. |
|
|
| Designing For Full cGMP Production At Pilot Scale | Article | By Dr. Nandu Deorkar Ph.D., Avantor | Explore how early adoption of fully compendial, cGMP raw materials can provide a return on investment by reducing steps in your process and potential yield losses. |
|
|
|
| Biomanufacturing Using Single-Use Systems: Fluoropolymer Material | Poster | By Julien Muzard, Joy Chen, Muhammad Siddiqui, and Ross Acucena, Entegris, Inc. | The industry is shifting from traditional processes to take advantage of single-use technology benefits. Discover how you can bypass traditional biomanufacturing and disposable multilayered films. |
|
|
|
|
|
| Complex protein-based therapies don’t play by the same process-engineering rules as small molecules and traditional biologics. They require developers to see the unforeseen and embrace new roles and responsibilities in sourcing raw materials and outsourced expertise. Successful developers can’t let this winding road slow their time to IND. Join Bioprocess Online Live on August 8th for an interactive discussion on early workflow considerations for complex protein-based therapeutics. Supported by Thermo Fisher Scientific. |
|
|
|
|
|
| Connect With Bioprocess Online: |
|
|
|
.png)
